Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 32, Number 4—April 2026

Research

Accelerated Increase in Candida auris Bloodstream Infections during COVID-19 Pandemic, South Africa

Husna Ismail, Olga Perovic, Ruth Mpembe, Warren Lowman, Chetna Govind, Pieter Ekermans, Waasila Jassat, Richard Welch, and Nelesh P. GovenderComments to Author 
Author affiliation: National Institute for Communicable Diseases, a Division of the National Health Laboratory Service, Johannesburg, South Africa (H. Ismail, O. Perovic, R. Mpembe, W. Jassat, R. Welch, N.P. Govender); University of the Witwatersrand, Johannesburg, South Africa (R. Mpembe, W. Lowman, N.P. Govender); Vermaak and Partners/Pathcare Pathologists, Pretoria, South Africa (W. Lowman); Wits Donald Gordon Medical Centre, Johannesburg (W. Lowman); Lancet Laboratories, Durban, South Africa (C. Govind); Ampath Microbiology National Reference Laboratory, Centurion, South Africa (P. Ekermans)

Main Article

Table

Distribution of 6 Candida species isolated from bloodstream infection by health sector in study of accelerated increase in Candida auris bloodstream infections during COVID-19 pandemic, South Africa, January 2019–June 2022

Category Candida species No. (%)
p value
2019 2020 2021 2022 Total
National
Candida albicans 793 (23) 959 (23) 1,200 (23) 597 (25) 3,549 (23) 0.26
Candida auris 597 (17) 1,012 (24) 1,626 (31) 693 (28) 3,928 (26) <0.01
Nakaseomyces glabratus* 332 (10) 339 (8) 359 (7) 209 (9) 1,239 (8) <0.01
Pichia kudriavzevii 63 (2) 93 (2) 73 (1) 31 (1) 260 (2) 0.01
Candida parapsilosis 1,555 (46) 1,734 (41) 1,955 (37) 836 (34) 6,080 (39) <0.01
Candida tropicalis 75 (2) 92 (2) 102 (2) 68 (3) 337 (2) 0.11
Total
3,415 (100)
4,229 (100)
5,315 (100)
2,434 (100)
15,393 (100)

Private
C. albicans 364 (15) 431 (15) 605 (16) 266 (16) 1,666 (15) 0.88
C. auris 580 (24) 863 (30) 1,439 (37) 625 (37) 3,507 (32) <0.01
N. glabratus 172 (7) 163 (6) 190 (5) 127 (8) 652 (6) 0.01
P. kudriavzevii 22 (1) 51 (2) 39 (1) 6 (0.4) 118 (1) 0.01
C. parapsilosis 1,217 (51) 1,329 (46) 1,567 (40) 629 (37) 4,742 (44) <0.01
C. tropicalis 38 (2) 32 (1) 40 (1) 31 (2) 141 (1) 0.04
Total
2,393 (100)
2,869 (100)
3,880 (100)
1,684 (100)
10,826 (100)

Public C. albicans 429 (42) 528 (39) 595 (41) 331 (44) 1883 (41) 0.11
C. auris 17 (2) 149 (11) 187 (13) 68 (9) 421 (9) <0.01
N. glabratus 160 (16) 176 (13) 169 (12) 82 (11) 587 (13) 0.01
P. kudriavzevii 41 (4) 42 (3) 34 (2) 25 (3) 142 (3) 0.14
C. parapsilosis 338 (33) 405 (30) 388 (27) 207 (28) 1338 (29) 0.01
C. tropicalis 37 (4) 60 (4) 62 (4) 37 (5) 196 (4) 0.59
Total 1,022 (100) 1360 (100) 1435 (100) 750 (100) 4,567 (100)

*Previously Candida glabrata.†Previously Candida krusei.

Main Article

Page created: February 07, 2026
Page updated: April 02, 2026
Page reviewed: April 02, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external